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Jembrana disease virus) is an acute lentiviral infection of Bali cattle in Indonesia. Data generated during
a series of cattle infection experiments was examined and signiﬁcant differences were identiﬁed in the mean
plasma viral load on the ﬁrst and second days of the febrile response in cattle infected with JDVTAB/87
compared to those infected with JDVPUL/01. The peak and total viral loads z106 genome copies/ml during the
acute stage of the disease were signiﬁcantly higher in JDVTAB/87 infected cattle. JDVPUL/01 infected cattle
developed peak rectal temperatures earlier than the JDVTAB/87 cattle but there were no differences in the
duration of the febrile responses observed for the 2 groups of animals. The plasma viremia was above 106
genome copies/ml for almost 3 days longer in JDVTAB/87 compared to JDVPUL/01 infected cattle. Atypical
responses to infection occurred in approximately 15% of experimentally infected animals, characterized by
reduced viral loads, lower or absent febrile responses and absence of p26-speciﬁc antibody responses. Most
of these cattle developed normal Tm-speciﬁc antibody responses between 4–12 weeks post-infection.
© 2009 Elsevier Inc. All rights reserved.Introduction
Jembrana disease virus (JDV) is a lentivirus which was ﬁrst
reported in Indonesia in 1964, causing high mortalities in Bali cattle
(Bos javanicus) on the island of Bali. The disease is now endemic in Bali
and has subsequently occurred in Bali cattle in Java, Sumatra and
Kalimantan (Indonesian Borneo). Infection of Bali cattle with JDV
causes an acute febrile response lasting 5–12 days after a short
incubation period, and animals characteristically develop anorexia,
leukopenia mainly due to a lymphopenia, oral erosions and enlarge-
ment of superﬁcial lymph nodes during the febrile period (Soesanto
et al., 1990). High levels of infectious virus (108 ID50/ml plasma) were
detected during the febrile response by titration in susceptible
animals, reducing to 105 ID50/ml on the ﬁrst day after the febrile
period and further declining to about 10 ID50/ml at 42 and 72 days
after infection (Soeharsono et al., 1995). The case fatality rate was
estimated to be 17% (Soeharsono et al., 1990) and surviving animals
were found to be resistant to re-infection, did not appear to suffer
relapses and remained viremic for at least 2 years (Soeharsono et al.,
1990). There is evidence of immunosuppression during the acute
stage of Jembrana disease resulting in a delayed seroconversion toport).
Tropical Medicine, Keppel St.,
ll rights reserved.viral proteins (Hartaningsih et al., 1994). Attempts to cultivate JDV in
vitro have so far been unsuccessful (Wilcox et al., 1992). An inactivated
tissue-derivedwhole virus vaccine has been produced which has been
found to ameliorate the febrile response and the leukopenia that occur
post-infection (Hartaningsih et al., 2001).
The early responses to JDV infection in cattle were determined by
monitoring the development of clinical signs,without quantiﬁcation of
the virus load (VL) during infection. Methods for quantiﬁcation of
lentiviruses without using traditional cell culture techniques are now
well established, with surrogate assays such as measurement of HIV-1
p24 capsid protein, reverse transcriptase (RT) activity and amount of
viral genomic RNA all currently being used (Marozsan et al., 2004;
Schutten et al., 2000; Sutthent et al., 2003). The recent development of
a JDV speciﬁc quantitative real-time reverse transcription PCR assay
(qRT-PCR) has enabled the quantiﬁcation of viral RNA genomes in
plasma samples taken during the course of infection, providing data
that can be used to assess vaccine efﬁcacy and strain differences
(Stewart et al., 2005). A piecewise linear regressionmodel has recently
been used to facilitate calculation of area under the curve (AUC) to
demonstrate a reduction in the duration andmagnitude of the plasma
VL after vaccination with an inactivated whole virus vaccine and
homologous challenge with JDVTAB/87 (Ditcham et al., 2009).
Most lentiviruses have relatively labile genomes which are prone
to variation and the development of quasispecies is common (Delwart
et al., 1994; Leroux et al., 2001). A recent phylogenetic analysis of JDV
env sequences has revealed that the JDVPUL/01 strain clustered
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insertion in the U3 region of the LTR relative to JDVTAB/87 (Desport
et al., 2007). Differences in viral tropism and replication rates have
been attributed to variations in this region of the LTR in Maedi-visna
virus and Equine infectious anemia virus (EIAV) (Barros, Andresdottir,
and Fevereiro, 2005; Lichtenstein et al., 1999). In addition, only 1 of 20
cattle was successfully infected after plasma from a JDVPUL/01 donor
animal on the second day of fever (rectal temperature ≥39.5 °C) was
diluted 10−5 to give an estimated challenge dose of 1000 ID50. The
plasma from JDVTAB/87 infected animals has been shown to consis-
tently contain ≥108 ID50/ml at this stage of the febrile response
(Soeharsono et al., 1990). We sought to determine whether there was
any evidence of variation in replication dynamics and viral loads
between JDVTAB/87 and JDVPUL/01 strains in vivo by comparing the viral
loads during the acute stage of the disease in groups of cattle that had
been experimentally infected with JDV.
Results
Clinical responses to infection with JDVTAB/87 and JDVPUL/01
The rectal temperatures of 26 Bali cattle experimentally infected
with JDV were compared to determine the range of values that are
normally observed during the acute phase of Jembrana disease
(Table 1). In 19 of the 26 experimentally infected animals, the clinical
disease followed a typical course; an incubation period of 5–12 days,
followed by a febrile response with a range of clinical signs, resolving
as the rectal temperature returned to normal 13–17 days post-
infection (Table 1). The groups that were infected with JDVPUL/01
developed peak rectal temperatures on average 1.5 days before those
infected with JDVTAB/87 but therewere no signiﬁcant differences in the
duration ormagnitude of the febrile responses or the number of days toTable 1
Observed data (days post-infection) for the onset, peak and end of the febrile response and
41.2 °C), high (N41.2 °C) and total febrile periods for 26 cattle experimentally infected with
Cattle no. Day post-infection
Peak VL ≥39.3 °C Peak °C b39.3
CB 61 10 5 11
CB 62 11 8 11
CB 63 8 7 11
CB 64 14 16 17
CB 83 12 7 11
CB 84 13 12 12
CB 85 11 9 11
CB 86 12 7 12
CB 203 12 8 13
CB 206 12 3 13
CB 208 11 8 11
CB 210 12 9 12
Mean 11.5 8.3 12.1
Var 2.1 9.9 2.7
CB 108 10 5 12
CB 109 10 (4) 9 (4) 11 (5) 13
CB 110 11 10 12
CB 111 14 (3) 12 (7) 13 (10)
CB 134 14 4 4
CB 135 13 9 11
CB 136 12 12 12
CB 137 12 9 11
CB 138 10 9 12
CB 154 11 8 10
CB 155 11 7 10
CB 156 11 8 10 13
CB 157 11 10 10
CB 158 10 9 10
Mean 11.4 8.6 10.6
Var 1.8 4.7 4.2
P-valuea 0.901 0.721 0.062
Atypical responders are highlighted in bold.
a P-values represent statistical differences between animals infected with JDVTAB/87 and Jrecovery (Table 1). This is illustrated in Fig. 1 by the rectal temperature
of CB137 (JDVPUL/01) which peaked at 11 days post-infection compared
to the temperature of CB210 (JDVTAB/87) which peaked at 12 days post-
infection. However, peak VL developed 8–14 days post-infection with
no difference in themean time to peak VL in either group (Table 1). The
observed and ﬁtted data generated using the piecewise linear
regression were closely aligned for the typical responders in both
groups of animals (CB210 and CB137 shown in Fig. 1).
Four animals CB64, CB84, CB134 and CB136 did not develop a
typical febrile response but instead a transient mild fever for 1–2 days
but they were all found to have detectable levels of circulating virus
(Fig. 2). Two patterns of viral replication were seen in these animals.
In CB64, CB84 and CB134 there was an undulating viremia increasing
to a maximum titer of approximately 108 genomes/ml which resulted
in differences between the observed and ﬁtted VL data (Fig. 2). In
CB136 there was a more typical pattern of viral increase and decrease
but with lower viral titers compared to the typical responders. In
addition, 3 cattle CB109, CB111 and CB156 died after infection with
JDVPUL/01. CB111 exhibited a severe leukopenia (data not shown) and
detectable viremia within 3 days of infection resulting in a poor ﬁt
between observed and ﬁtted data (Fig. 3). After a prolonged period of
elevated rectal temperatures (13 days) this animal subsequently died.
CB109 also developed an early transient fever and died as the febrile
response was resolving. CB156 appeared to be following the typical
course of infectionwith the febrile response resolving at 13 days post-
infection but was unable to clear the virus and subsequently died
(Fig. 3). This failure to clear virus was a common feature of these
animals as they were all found to have high plasma viral loads at death
but Fischers exact test did not indicate any signiﬁcant differences
(P=.140) in fatalities between the 2 groups of cattle. These were the
only fatalities giving a mortality rate of 21% for cattle experimentally
infected with JDVPUL/01.peak viral load together with duration (days) of low (39.3–40.2 °C), moderate (40.3–
1000 ID50/ml JDVTAB/87 (CB61–CB210) or JDVPUL/01 (CB108–CB158)
Duration of febrile response (days)
°C Low Moderate High Total
14 5 3 0 8
15 3 3 1 7
14 0 6 1 7
19 2 0 0 2
14 3 4 0 7
13 1 0 0 1
15 2 4 0 6
15 3 5 0 8
15 4 5 0 9
15 6 1 0 7
14 2 2 1 5
17 3 5 0 8
15 2.8 3.2 0.3 6.3
2.33 2.5 3.8 0.2 5.5
14 3 4 2 9
died 14 4 1 0 5
13 2 1 0 3
18 died 9 4 0 13
5 1 0 0 1
16 4 2 2 8
13 1 0 0 1
15 2 5 0 7
15 1 4 0 5
14 1 5 0 6
14 4 2 1 7
died 14 4 2 0 6
14 3 1 0 4
14 2 2 1 5
13.6 2.9 2.4 0.4 5.7
7.5 4.2 2.8 0.5 9.2
0.156 0.901 0.285 0.482 0.637
DVPUL/01.
Fig.1.Dynamics of viral replication in CB210 after infectionwith 1000 ID50/ml JDVTAB/87
and CB137 after infection with 1000 ID50/ml JDVPUL/01. Rectal temperatures (□) were
collected for up to 22 days post-infection. Plasma VL (JDV genome copies/ml plasma)
was determined using qRT-PCR (●) and transformed to log10 scale. Differences in VL
were calculated using a threshold of 106 genome copies/ml plasma (solid line) and AUC
was determined from measured plasma VL (●) and ﬁtted VL, calculated using the
piecewise linear regression model (−−), where measured data was unavailable.
Fig. 2. Dynamics of viral replication in atypical responders after infection with 1000 ID50/
temperatures (□) were collected for up to 22 days post-infection. Plasma VL (JDV genome
Differences in VL were calculated using a threshold of 106 genome copies/ml plasma (solid
using the piecewise linear regression model (−−), where measured data was unavailable.
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The mean plasma VL on the ﬁrst and second days of the febrile
response in the cattle infected with JDVPUL/01 were signiﬁcantly lower
(P=.046 and P=.033 respectively) than in cattle infected with
JDVTAB/87 (Table 2). Similarly, the mean peak VL was signiﬁcantly
lower in JDVPUL/01 infected animals (P=.049). JDVTAB/87 infected
cattle were found to have a mean log10 plasma VL ≥106 genomes/ml
of 11.2 compared to 10.26 for JDVPUL/01 infected cattle during the acute
stage of Jembrana disease. This is approaching signiﬁcance (P=.056)
and is reﬂected in the signiﬁcant difference of almost 3 days in the
mean number of days that cattle were found to have plasma VL above
this threshold in the 2 groups of animals (P=.018) (Table 2).
Analysis of variance within strains
When the variation in clinical responses to infection with either
strain of JDVwas analysedwithin groups infectedwith the same strain
there were no signiﬁcant differences. However cattle infected with
JDVPUL/01 in group IVwere found to have a signiﬁcantly higher peak VL
(P=.033) and AUC ≥106 genomes/ml (P=.034) than the cattle in
groups V and VI. In cattle infected with JDVTAB/87 signiﬁcant
differences in VL were observed in the cattle in group II on the ﬁrst
(P=.056) and second (P=.033) days of elevated rectal temperatures
(N39.3 °C) when compared to groups III and VII.
Development of antibody responses post-infection
The 8 typical responders that were sampled beyond the recovery
period of Jembrana disease developed detectable anti-capsid antibody
responses 5–15 weeks post-infection (Fig. 4). A small transient
increase in antibody levels was seen in some animals at 2 weeksml JDVTAB/87 (CB64 and CB84) or 1000 ID50/ml JDVPUL/01 (CB134 and CB136). Rectal
copies/ml plasma) was determined using qRT-PCR (●) and transformed to log10 scale.
line) and AUC was determined from measured plasma VL (●) and ﬁtted VL, calculated
Fig. 3. Dynamics of viral replication in fatal cases of Jembrana disease after infection with 1000 ID50/ml JDVPUL/01. Plasma VL (JDV genome copies/ml plasma) was determined using
qRT-PCR (●) and transformed to log10 scale. Differences in VL were calculated using a threshold of 106 genome copies/ml plasma (solid line) and AUC was determined from
measured plasma VL (●). Rectal temperatures (□) were collected until the day of death.
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26 weeks. The 4 atypical responders did not develop responses that
were detectable using the JDV p26-his ELISA within the period of
sampling (Fig. 5) although very weak responses were observed by
Western immunoblotting (data not shown). Antibody responses
detected using the JDV Tmc peptide were observed in all cattle,
including the atypical responders with the exception of CB134.
Discussion
Experimental infection with different strains of JDV resulted in a
broad spectrum of responses, ranging from an absence of any clinical
signs of disease in 15% of cattle to fatalities in 11.5% of cattle. This high
level of animal to animal variation can obscure the effects of
vaccination or strain variation when using small numbers of animals
per group. Quantiﬁcation of the magnitude and duration of VL ≥106
genome copies/ml has revealed the beneﬁts of using JDVacc, a whole
virus inactivated vaccine that is currently used in Indonesia (Ditcham
et al., 2009) and highlighted the problems associated with correlating
febrile responses with vaccine efﬁcacy. The data presented in this
study reveals differences in the magnitude and duration of plasma VL
generated after infection with JDVPUL/01 compared to JDVTAB/87 which
could be associated with the phylogenetic separation of JDVPUL/01
from other Bali strains based on env sequences (Desport et al., 2007).
Animals infected with JDVTAB/87 exhibited higher and longer plasma
VL compared to those infected with JDVPUL/01 which could be due to
both host and virus factors. Co-infection with other pathogens,
particularly those such as helminths which cause immune activation,
are host-speciﬁc contributing factors which have been identiﬁed in
the spread and progression of HIV in developing countries (Bentwich
et al., 2000). Small changes in lentivirus gene sequences can confer
signiﬁcant phenotypic changes in the virus. Simultaneous mutations
in the capsid and vif genes have been shown to confer a highlypathogenic phenotype on a non-pathogenic infectious clone of Maedi-
visna virus (Gudmundsson et al., 2005). Differences in LTR sequences
have been correlated with an increased replication capacity of EIAV
in vitro (Madden and Shih, 1996) and it is possible that the 7
nucleotide insertion in the U3 region of the LTR of JDVPUL/01 (Desport
et al., 2007) may be contributing towards at least some of the
differences in the viral replication dynamics. Expression and regula-
tion of mRNA transcripts can inﬂuence both lentiviral replication and
disease pathogenesis (Schiltz et al., 1992; Unger, Stout, and Luciw,
1991). We have recently reported differences in the splicing patterns
of mRNA transcripts encoding the Tat proteins of these two virus
strains (Setiyaningsih et al., 2008). Two small non-coding exons were
identiﬁed in transcripts obtained from JDVPUL/01 whereas only one
non-coding exon was identiﬁed in the JDVTAB/87 transcripts. Small
non-coding exons have been identiﬁed in HIV-1 mRNA leader
sequences and are associated with changes in gene expression and
the cell type from which the transcripts were derived (Krummheuer
et al., 2001).
Atypical responses were seen in 4 of the cattle infected with either
JDVTAB/87 or JDVPUL/01 and their lower peak VL was associated with
reduced or absent clinical signs. Atypical responses to infection have
been reported in a small proportion of mock-vaccinated cats in feline
immunodeﬁciency virus (FIV) vaccine trials where they were found to
be naturally resistant to FIV, even after more than one challenge
(Verschoor et al., 1996). Two EIAV strains appear to have different
disease induction capabilities in horseswhich correlatewith nucleotide
differences in the 3′ region of the genome. Based on these observations,
it has been postulated that a threshold level of EIAV is required for
induction of acute disease in horses (Cook et al., 2003). Similarly, high
levels of SIVsmmPBj14 in the plasma of pig-tailed macaques was
associated with a virus threshold beyond which a synergistic cycle of
lymphoid activation and viral replication accelerates uncontrollably
resulting in the acutely lethal syndrome (Schwiebert and Fultz, 1994).
Fig. 4. Development of IgG responses to recombinant JDV p26 in (a) typical CB61 (■),
CB62 (▴), CB83 (▾), CB85 (♦), CB86 (●), CB135 (♦), CB137 (x) and CB138 (l) and (b)
atypical CB64 (■), CB84 (▴), CB134 (▾) and CB136 (♦) responders after experimental
infection with JDVTAB/87 (CB61–64, CB83–86) or JDVPUL/01 (CB134–138).
Table 2
Comparison of plasma VL on the ﬁrst and second days of febrile response, peak VL,
area under curve (AUC) for plasmaVL≥106 genome copies/ml anddurationof AUCz106
genome copies/ml for 26 cattle experimentally infectedwith JDVTAB/87 (CB61–CB210) or
JDVPUL/01 (CB108–CB158)
Animal Log10 VL 1st
day ≥39.3 °C
Log10 VL 2nd
day ≥39.3 °C
Log10
peak VL
Log10 AUC z106
genome
copies/ml
Days AUCz106
genome
copies/ml
CB 61 11.34 11.81 12.22 12.74 13.8
CB 62 11.09 11.47 11.97 12.57 15.7
CB 63 10.56 11.29 11.29 11.89 12.9
CB 64 10.48 10.12 11.19 11.41 8.9
CB 83 10.08 10.97 11.76 12.22 12.2
CB 84 7.08 N/A 7.93 8.33 7.3
CB 85 10.06 10.36 10.63 11.02 9
CB 86 9.15 10.33 11.10 11.62 11.9
CB 203 9.98 10.28 10.73 11.18 16.39
CB 206 9.40 10.01 10.18 10.55 10.30
CB 208 7.54 8.95 10.02 10.22 10.70
CB 210 9.16 10.00 10.13 10.60 13.40
Mean 9.66 10.55 10.81 11.20 11.88
Var 1.68 0.66 1.48 1.46 7.65
CB 108 6.29 6.37 10.64 11.19 11.7
CB 109 10.67 11.36 11.36 11.87 10
CB 110 9.95 11.19 11.19 11.65 10
CB 111 6.21 6.01 10.74 11.18 11.8
CB 134 1.57 N/A 8.29 8.29 3
CB 135 9.74 10.46 10.58 11.23 13.9
CB 136 7.81 N/A 7.81 8.22 9.2
CB 137 9.56 9.35 10.42 10.78 11.1
CB 138 8.08 10.35 10.35 10.46 8.7
CB 154 8.43 8.79 9.19 9.42 6.9
CB 155 8.83 9.54 9.69 10.14 9.6
CB 156 9.18 9.50 9.99 10.48 7.8
CB 157 8.83 8.94 8.94 9.35 8
CB 158 8.29 9.06 9.06 9.32 6.5
Mean 8.10 9.24 9.87 10.26 9.16
Var 5.14 2.74 1.16 1.39 7.34
P-valuea .046 .033 .049 .056 .018
Atypical responders are highlighted in bold.
a P-values represent statistical differences between animals infected with JDVTAB/87
and JDVPUL/01.
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same strain of virus indicated that there were some group speciﬁc
factors contributing towards these differences. The signiﬁcantly
higher VL in cattle in group II at the onset of the febrile response
could have occurred as a result of a higher titer of infectious virus in
the challenge dose prepared for this group. There were no differences
between the peak VL for these groups conﬁrming earlier studies
which showed that there was no detectable relationship between the
dose and the severity and duration of the disease induced (Soehar-
sono et al., 1990). The differences between groups infected with
JDVPUL/01 were due to higher peak VL and AUC z106 genome copies/
ml in cattle in group IV compared to groups V and VI. This suggests
that group speciﬁc factors such as poor nutrition (unpublished
observation) or the introduction of additional infectious agents in
the challenge dose may have contributed to the higher VL and
subsequent fatalities of 50% of the cattle in this group.
During the recovery phase of Jembrana disease the earliest
detectable immune response is against the JDV capsid protein
(Hartaningsih et al., 1994). Capsid antibody responses are used as
diagnostic indicators of bovine lentiviral infections (Barboni et al.,
2001; Burkala et al., 1999; Meas et al., 2000) but the absence of
detectable responses in 4 of the 12 animals in this study suggests that
these diagnostic assays may be underestimating the prevalence of
infection. Failure to mount a detectable antibody response has also
been observed in other lentivirus infections. Immune dysfunction in
persons who are HIV-1-infected but who remain persistently
seronegative has been suggested to account for the lack of detectable
antibody response, although in this case the absence of antibodies
appears to correlatewith quick onset or rapid progression of disease in50% of these cases (Ellenberger et al., 1999). FIV genome-positive
seronegative cats have been reported after being housed with
seropositive FIV-infected cats and it is thought that this could be
due to delayed seroconversion, infection with defective virus or
atypical routes of infection (Dandekar et al., 1992). Robust antibody
responses to envelope glycoproteins have been reported in the
absence of core antigen p28 speciﬁc antibodies in African green
monkeys naturally infected with SIVAGM (Norley et al., 1990). This was
associated with a lack of virus trapping in lymph nodes and non-
progression to AIDS and it is suggested to occur as a result of T-cell
tolerance to gag resulting in protection from the catastrophic demise
of the immune system (Norley and Kurth, 2004). The signiﬁcance of
these different humoral responses in JDV infected cattle remains to be
determined.
A linear relationship between the infectious doses used in JDV
experimental infections and the incubation period before onset of
disease has been identiﬁed in previous studies and provides some
additional evidence of differences in replication rates between JDV
strains (Soeharsono et al., 1990). Tenfold dilutions of whole blood
from donor animals infected with either Singaraja/86 strain (JDVSING/
86) or JDVTAB/87 were inoculated into naïve cattle and a consistently
longer incubation period was seen in the cattle challenged with
JDVSING/86 compared to those challenged with the same dilution of
JDVTAB/87.
The comparison of plasma VL on the ﬁrst 2 days of fever in cattle
infected with different strains of JDV clearly showed that JDVPUL/01
infected cattle developed fever at a lower plasma VL compared to
cattle infected with JDVTAB/87. Thus the infection of only 1/20 cattle
with a 10−5 dilution of plasma from a JDVPUL/01 donor animal taken on
the second day of fever was almost certainly due to a lower titer of
virus rather than an atypical response to infection. The development
of the JDV p26 capture ELISA has provided an indirect method to
quantify VL in donor animals and was used for preparation of
Table 3
Cattle numbers, groups and strain of JDV used for infection
Cattle no. JDV strain
Group II CB61 CB62 CB63 CB64 JDVTAB/87
Group III CB83 CB84 CB85 CB86 JDVTAB/87
Group IV CB108 CB109 CB110 CB111 JDVPUL/01
Group V CB134 CB135 CB136 CB137 CB138 JDVPUL/01
Group VI CB154 CB155 CB156 CB157 CB158 JDVPUL/01
Group VII CB203 CB206 CB208 CB210 JDVTAB/87
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et al., 2005). Unfortunately the lower plasma VL in JDVPUL/01 infected
animals did not correlate with any attenuation of the virus as all of the
mortalities were observed in cattle infected with this strain of virus.
The correlation between lower or absent febrile responses in the
atypical responders and reduced peak viral loads suggests that a
threshold of disease induction may exist for JDV and that a vaccine
which is able to effect a 10–100 fold reduction in viral load may be
sufﬁcient to control the spread of Jembrana disease in Indonesia.
Materials and methods
Experimental infection with JDVTAB/87 or JDVPUL/01
Female Bali cattle 6–12 months of age were purchased from Nusa
Penida, an island off the coast of Bali that is free of Jembrana disease.
The animals were housed indoors and tested by ELISA for JDV capsid
serum antibody (Hartaningsih et al., 1994) to ensure that they had not
been infected previously. Live viral challenge doses were prepared by
inoculation with virus strains JDVTAB/87 or JDVPUL/01 into seronegative
donor animals as described previously (Soeharsono et al., 1995). The
plasma viral load in the donor animals was determined using antigen
capture ELISA as described previously (Stewart et al., 2005) and fresh
plasma samples were diluted to give approximate challenge doses of
1000 ID50/ml. The cattle used in this study were derived from a series
of experimental infection trials and therefore different donor animals
were used to prepare challenge doses for each group (Table 3).
Sampling intervals varied between the groups and only cattle from
groups II, III and Vwere sampled beyond the acute stage of the disease
for between 11 and 26 weeks post-infection. Rectal temperatures
were taken daily for 21 days post-infection. For data analysis in this
study, rectal temperatures were divided into ranges adapted from the
method of Muraguri et al. (1999) taking 39.3 °C as the lowestFig. 5. Development of IgG responses to recombinant JDV Tmc peptide in (a) typical
CB61 (■), CB62 (▴), CB83 (▾), CB85 (♦), CB86 (●), CB135 (♦), CB137 (x) and CB138 (l)
and (b) atypical CB64 (■), CB84 (▴), CB134 (▾) and CB136 (♦) responders after
experimental infection with JDVTAB/87 (CB61–64, CB83–86) or JDVPUL/01 (CB134–138).signiﬁcant temperature indicating fever. The ranges were deﬁned as
low fever (39.3 °C–40.2 °C), moderate fever (40.3 °C–41.2 °C) and high
fever (N41.2 °C). Whole blood samples were taken into EDTA for
preparation of plasma and PBMC and serum samples were prepared
by centrifugation from clotted blood taken into tubes without EDTA.
All samples were stored at −80 °C until analysis. Clinical signs were
monitored until recovery.
Viral RNA quantiﬁcation
Plasma samples were centrifuged (8000 g, 5 min) prior to
extraction of RNA. Viral RNA from 140 μl (280 μl for CB83–86) of
recently thawed plasma from each sample was extracted using a
QIAmp Viral RNA mini kit (Qiagen) following the manufacturer's
instructions, with a ﬁnal elution volume of 60 μl in buffer EB. Extracted
RNA was stored at −80 °C until assayed. The primer set utilized was
JDV gag1f (TGGGAAGCATGGACAATCA) and JDV gag1r (GGAGACCCGT-
CAGATGTGGA) which speciﬁcally ampliﬁed a 118 bp fragment of the
JDV gag gene. The ﬂuorogenic probe (CCCACAACTTAGAAA-
GAACTTCCCCGCTG) was labeled at the 5′ end with the reporter dye
FAM and at the 3′ end with the quencher dye BHQ-1. The qRT-PCR
reactions were performed in a Rotor-Gene 3000 (Corbett Research).
RNA samples from groups II–IV were quantiﬁed using an Access RT-
PCR kit (Promega) as previously described (Stewart et al., 2005) using
2 μl of extracted viral RNA per reaction. The one-step RT-PCR protocol
consisted of an RT step at 48 °C for 45 min, a 3 min inactivation step at
95 °C, followed by 40 cycles of 95 °C for 30 s, 58 °C for 30 s and 60 °C for
30 s. RNA samples obtained from the animals in group V, VI and VII
were analyzed using a premixed 2× mastermix (Iscript, BioRad), with
the addition of both primers and ﬂuorogenic probe to a ﬁnal
concentration of 100 nM as above, and ultrapure water added to
give a ﬁnal 1× concentration. MMLV reverse transcriptase was used in
this assay following the manufacturers' instructions. One microliter of
RNA sample was added to 9 μl of mastermix and the one-step RT-PCR
protocol consisted of an RT step of 50 °C for 10 min, a 5 min
inactivation step at 95 °C with a 2 s pause at 92 °C to prevent thermal
overshoot, followed by 40 cycles of 92 °C for 2 s, 95 °C for 15 s and
58 °C for 30 s and 60 °C for 30 s. A standard curve was generated in
each run by ampliﬁcation of duplicate serial 10-fold dilutions of a
plasmid containing nucleotides 19–2881 of JDVTAB/87 strain, encom-
passing the target amplicon. Copy numbers of the plasmid added to
each standard reaction were calculated, with one copy of plasmid
equivalent to one viral genome.
Development of anti-JDV IgG responses post-infection
Serum samples were tested by ELISA using JDV capsid protein with
a hexa-histidine tag (JDVp26-his) produced fromaplasmid containing
JDV capsid in pTrcHisB (a kind gift from Dr. M. Collins). A JDV TM
peptide (KVQTGLGCVPRGRYCHFD) reported to encompass the princi-
pal immunodominant domain of JDV Tm (Barboni et al., 2001) was
synthesized in linear form (Proteomics International, Perth) and
dissolved in 0.01 M ammonium acetate to form a cyclic peptide (JDV
Tmc peptide) as previously described (Scobie et al., 1999). Sera were
tested at dilutions of 1:100 (JDV p26-his) or 1:16 (JDV Tmc peptide)
usingMaxisorb plates (NUNC) coatedwith 12.5 to 50 ng of antigen per
316 M. Desport et al. / Virology 386 (2009) 310–316well or with 1 μg JDV Tmc peptide per well diluted in 0.1 M NaHCO3
buffer (pH 9.5). Blocking was performed at room temperaturewith 5%
skimmed milk in PBS-0.05% Tween 20 (PBST) for 1 h. Serum dilutions
in blocking solution were incubated for 1 h at 37 °C followed by a
1:2000 dilution of horseradish peroxidase labeled rabbit anti-bovine
IgG (ICN) in PBS/T for 1 h at 37 °C. HRP substrate reagent (BioRad)was
added to thewells and allowed to develop for 15min. The reactionwas
stopped with 2% oxalic acid and the absorbance read at 405 nm.
Statistical analysis of viral load and temperature differences
Differences between JDVTAB/87 or JDVPUL/01 were assessed by
analyzing changes in rectal temperature and plasma VL in experimen-
tally infected cattle. Rectal temperatures were divided into ranges
adapted from the method of Muraguri et al. (1999) using 39.3 °C as the
lowest signiﬁcant fever. The VL on the ﬁrst and second days of elevated
rectal temperatures (N39.3 °C) and the peak and area under the curve
z106 genome copies/ml values for VL were log10 transformed to
stabilize the variance between groups. Variation between animals
infected with different strains and between groups infected with the
same strain was tested using ANOVA (Minitab). The area under curve
(AUC) of the plasma VL ≥106 genomes/ml was used to assess
differences in duration and magnitude of the VL. This threshold was
chosen as it has been shown to represent 99.995% of the total VL for the
control group in a recent vaccine trial (Ditcham et al., 2009) and
requires minimal estimation of data points. Three aspects of plasma VL
were compared: (i) peak VL; (ii) AUC plasma VL ≥106 genomes/ml;
and (iii) number of days where plasma VL ≥106 genomes/ml. The VL
(AUC) for each animal was estimated by summing the areas under each
pair of observations that form sets of trapezoids. The trapezoid-area
was determined as h⁎([v+w]/2), where h was the time in days
between consecutive viral determinations (denoted v and w) in
genomes/ml. The VL ≥106 genomes/ml was determined with a
baseline set at 106. Linear interpolation between consecutive observa-
tions was used to more accurately determine the time when VL
exceeded or fell below 106 genomes/ml. Sampling did not always
continue for long enough for the VL to reduce to 106 genomes/ml so
the piecewise linear model described previously (Ditcham et al., 2009)
was used to extrapolate beyond the last data point.
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